A phase II study of docetaxel in patients with metastatic carcinoid tumors

Cancer Investigation

Volumn 22, Issue 3, 2004, Pages 353-359

  Kulke, Matthew H ^a   Kim, Haesook ^a   Stuart, Keith ^b   Clark, Jeffrey W ^c   Ryan, David P ^c   Vincitore, Michele ^a   Mayer, Robert J ^a   Fuchs, Charles S ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Carcinoid tumors; Chemotherapy; Docetaxel; Neuroendocrine tumors

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CISPLATIN; DOCETAXEL; ETOPOSIDE; FLUOROURACIL; INTERFERON; STREPTOZOCIN;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOID; CLINICAL ARTICLE; CLINICAL TRIAL; COLON TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; DUODENUM TUMOR; DYSPNEA; EDEMA; FATIGUE; FEMALE; FOLLOW UP; HUMAN; LUNG TUMOR; MALE; METASTASIS; MULTICENTER STUDY; MYALGIA; NAUSEA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECTUM TUMOR; SMALL INTESTINE TUMOR; STOMATITIS; SURVIVAL TIME; THORAX RADIOGRAPHY; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOID TUMOR; DISEASE-FREE SURVIVAL; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMAN; HYDROXYINDOLEACETIC ACID; LIFE TABLES; LUNG NEOPLASMS; MALE; MIDDLE AGED; OCTREOTIDE; SALVAGE THERAPY; SURVIVAL ANALYSIS; TAXOIDS; TREATMENT FAILURE;

EID: 4744365811     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-200029058     Document Type: Article

References (19)

1. Modlin, I.M.; Sandor, A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997, 79, 813-829.
2. Godwin, J.D. Carcinoid tumors: an analysis of 2837 cases. Cancer 1975, 36, 560-569.
3. Kulke, M.; Mayer, R. Carcinoid tumors. N. Engl. J. Med. 1999, 340, 858-868.
4. Kvols, L.; Moertel, G.G.; O'Connell, M.J.; Schutt, A.J.; Rubin, J.; Hahn, R.G. Treatment of the malignant carcinoid syndrome: evaluation of a long-acting somatostatin analog. N. Engl. J. Med. 1986, 315, 663-666.
5. Rubin, J.; Ajani, J.; Schirmer, W.; Venook, A.P.; Bukowski, R.; Pommier, R.; Saltz, L.; Dandona, P.; Anthony, L. Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome. J. Clin. Oncol. 1999, 17, 600-666.
6. DiBartolomeo, M.; Bajetta, E.; Buzzoni, R.; Mariani, L.; Carnaghi, C.; Somma, L.; Zilembo, N.; di Leo, A. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. Cancer 1996, 77, 402-408.
7. Oberg, K.; Eriksson, B. The role of interferons in the management of carcinoid tumors. Acta Oncol. 1991, 30, 519-522.
8. Moertel, C.G.; Hanley, J.A. Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome. Cancer Clin. Trials 1979, 2, 327-334.
9. Engstrom, P.; Lavin, P.T.; Moertel, C.G.; Folsch, E.; Douglass, H.O., Jr. Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor. J. Clin. Oncol. 1984, 2, 1255-1259.
10. Sparano, J.A. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials. Clin. Breast Cancer 2000, 1, 32-40.
11. Posner, M.R. Docetaxel in squamous cell cancer of the head and neck. Anticancer Drugs 2001, 12 (suppl. 1), S21-S24.
12. Georgoulias, V. Docetaxel (taxotere) in the treatment of non-small cell lung cancer. Curr. Med. Chem. 2002, 9, 869-877.
13. Kelly, K. New chemotherapy agents for small cell lung cancer. Chest 2000, 117, 156S-162S.
14. Kaplan, E.; Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1959, 53, 457-481.
15. Moertel, C.G. Treatment of the carcinoid tumor and the malignant carcinoid syndrome. J. Clin. Oncol. 1983, 1, 727-740.
16. Bukowski, R.; Tangen, C.M.; Peterson, R.F.; Taylor, S.A.; Rinehart, J.J.; Eyre, H.J.; Rivkin, S.E.; Fleming, T.R.; Macdonald, J.S. Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid. Cancer 1994, 73, 1505-1508.
17. Feldman, J.M.; O'Dorisio, T.M. Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors. Am. J. Med. 1986, 81 (suppl. 6B), 41-48.
18. Quaedvlieg, P.; Visser, O.; Lamers, C.B.; Janssen-Heijen, M.L.; Taal, E.G. Epidemiology and survival in patients with carcinoid disease in the Netherlands. Ann. Oncol. 2001, 12, 1295-1300.
19. Ansell, S.; Pitot, H.C.; Burch, P.A.; Kvols, L.K.; Mahoney, M.R.; Rubin, J. A phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors. Cancer 2001, 91, 1543-1548.